{"substancia": "DOLUTEGRAVIR;LAMIVUDINA", "lista": "20261009", "publicado_em": "09/10/2026 12:43:03", "pagina": "https://anvisa.feeds.abelhaninja.de/cmed/substancia/dolutegravir-lamivudina.html", "feed": "https://anvisa.feeds.abelhaninja.de/cmed/substancia/dolutegravir-lamivudina.xml", "mudancas": [], "apresentacoes": [{"ggrem": "510622030058805", "registro": "1010703530014", "produto": "DOVATO", "apresentacao": "(300 + 50) MG COM REV CT FR PLAS PEAD OPC X 30", "substancia": "DOLUTEGRAVIR;LAMIVUDINA", "cnpj": "33247743000110", "laboratorio": "GLAXOSMITHKLINE BRASIL LTDA", "tipo_produto": "Novo", "regime_preco": "Regulado", "tarja": "Tarja Vermelha", "pf_0": 241636, "pmc_0": 324146, "pmvg_0": 193816, "restricao_hospitalar": "N", "cap": "N"}]}